NAYA Biosciences EBITDA Margin 2010-2024 | IVF

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for NAYA Biosciences (IVF) over the last 10 years. The current EBITDA margin for NAYA Biosciences as of December 31, 2024 is .
NAYA Biosciences EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-12-31 $0.01B $-0.01B -100.00%
2024-09-30 $0.01B $0.00B -66.67%
2024-06-30 $0.01B $0.00B -66.67%
2024-03-31 $0.00B $-0.01B -125.00%
2023-12-31 $0.00B $-0.01B -300.00%
2023-09-30 $0.00B $-0.01B -800.00%
2023-06-30 $0.00B $-0.01B 0.00%
2023-03-31 $0.00B $-0.01B 0.00%
2022-12-31 $0.00B $-0.01B 0.00%
2022-09-30 $0.00B $-0.01B -266.67%
2022-06-30 $0.00B $-0.01B -233.33%
2022-03-31 $0.00B $-0.01B -200.00%
2021-12-31 $0.00B $0.00B -100.00%
2021-09-30 $0.00B $-0.01B -500.00%
2021-06-30 $0.00B $0.00B -400.00%
2021-03-31 $0.00B $0.00B -300.00%
2020-12-31 $0.00B $0.00B 0.00%
2020-09-30 $0.00B $0.00B 0.00%
2020-06-30 $0.00B $0.00B 0.00%
2020-03-31 $0.00B $0.00B -300.00%
2019-12-31 $0.00B $0.00B -200.00%
2019-09-30 $0.00B $0.00B -100.00%
2019-06-30 $0.00B 0 0.00%
2019-03-31 $0.00B $0.00B 0.00%
2018-12-31 $0.00B $0.00B 0.00%
2018-09-30 $0.00B $0.00B 0.00%
2018-06-30 $0.00B $0.00B 0.00%
2018-03-31 $0.00B 0 0.00%
2017-12-31 $0.00B 0 0.00%
2017-09-30 $0.00B 0 0.00%
2017-06-30 $0.00B 0 0.00%
2017-03-31 $0.00B $0.00B 0.00%
2016-12-31 $0.00B $0.00B 0.00%
2016-06-30 $0.00B $0.00B 0.00%
2016-03-31 $0.00B 0 0.00%
2015-09-30 $0.00B 0 0.00%
2015-06-30 $0.00B 0 0.00%
2015-03-31 $0.00B 0 0.00%
2011-12-31 $0.00B 0 0.00%
2011-09-30 $0.00B 0 0.00%
2011-03-31 $0.00B 0 0.00%
2010-12-31 $0.00B 0 0.00%
2010-06-30 $0.00B 0 0.00%
2010-03-31 $0.00B 0 0.00%
2009-12-31 $0.00B $0.00B 0.00%
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.001B $0.007B
NAYA Biosciences is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases and fertility. NAYA Biosciences, formerly known as INVO BIOSCIENCE, is based in SARASOTA, Fla.
Stock Name Country Market Cap PE Ratio
MYT Netherlands Parent B.V (LUXE) DE $0.631B 0.00
SAG Holdings (INEO) SG $0.013B 0.00
Aerovate Therapeutics (JBIO) US $0.008B 0.00